Anne Svensson

514 total citations
10 papers, 419 citations indexed

About

Anne Svensson is a scholar working on Molecular Biology, Pharmacology and Physiology. According to data from OpenAlex, Anne Svensson has authored 10 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pharmacology and 3 papers in Physiology. Recurrent topics in Anne Svensson's work include Nicotinic Acetylcholine Receptors Study (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anne Svensson is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (4 papers), Alzheimer's disease research and treatments (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Anne Svensson collaborates with scholars based in Sweden and Japan. Anne Svensson's co-authors include Agneta Nordberg, Dan Sunnemark, Harald Lund, Ove Almkvist, B. Strandberg, Hermona Soreq, Zhenpeng Guan, Anita Garlind, Ewa Hellström‐Lindahl and Taher Darreh‐Shori and has published in prestigious journals such as Neurology, Neuroscience and Neurobiology of Aging.

In The Last Decade

Anne Svensson

10 papers receiving 408 citations

Peers

Anne Svensson
N.K. Robakis United States
Heidy Jimenez United States
Barbara J. Blanchard United States
Roger Lefort United States
Yuan-Wen Ge United States
DH Small Australia
Anne Svensson
Citations per year, relative to Anne Svensson Anne Svensson (= 1×) peers Shigeru Akasofu

Countries citing papers authored by Anne Svensson

Since Specialization
Citations

This map shows the geographic impact of Anne Svensson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Svensson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Svensson more than expected).

Fields of papers citing papers by Anne Svensson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Svensson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Svensson. The network helps show where Anne Svensson may publish in the future.

Co-authorship network of co-authors of Anne Svensson

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Svensson. A scholar is included among the top collaborators of Anne Svensson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Svensson. Anne Svensson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Johannesson, Malin, Charlotte Sahlin, Linda Söderberg, et al.. (2021). Elevated soluble amyloid beta protofibrils in Down syndrome and Alzheimer's disease. Molecular and Cellular Neuroscience. 114. 103641–103641. 20 indexed citations
2.
Lund, Harald, et al.. (2014). MARK4 and MARK3 associate with early tau phosphorylation in Alzheimer’s disease granulovacuolar degeneration bodies. Acta Neuropathologica Communications. 2(1). 22–22. 80 indexed citations
3.
Lund, Harald, Richard F. Cowburn, Kia Strömberg, et al.. (2012). Tau‐Tubulin Kinase 1 Expression, Phosphorylation and Co‐Localization with Phospho‐Ser422 Tau in the Alzheimer's Disease Brain. Brain Pathology. 23(4). 378–389. 39 indexed citations
4.
Svensson, Anne, et al.. (2002). Chronic treatments with tacrine and (−)-nicotine induce different changes of nicotinic and muscarinic acetylcholine receptors in the brain of aged rat. Journal of Neural Transmission. 109(3). 377–392. 24 indexed citations
5.
Darreh‐Shori, Taher, Ove Almkvist, Zhenpeng Guan, et al.. (2002). Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months. Neurology. 59(4). 563–572. 137 indexed citations
7.
Svensson, Anne & Agneta Nordberg. (1999). β-Estradiol attenuate amyloid β-peptide toxicity via nicotinic receptors. Neuroreport. 10(17). 3485–3489. 39 indexed citations
8.
Svensson, Anne, et al.. (1996). Localization of the major allergenBet vI in birch pollen by confocal laser scanning microscopy. Grana. 35(4). 199–204. 13 indexed citations
9.
Svensson, Anne & Agneta Nordberg. (1996). 614 Interaction of tacrine, galanthamine, NXX-066 and E2020 with neuronal gb4 β2 nicotinic receptor expressed in fibroblast cells. Neurobiology of Aging. 17(4). S153–S153. 5 indexed citations
10.
Hage, Marianne van, et al.. (1995). Localization of major allergens in the dust mite Lepidoglyphus destructor with confocal laser scanning microscopy. Clinical & Experimental Allergy. 25(6). 536–542. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026